Abstract
Receptor binding provides a valuable approach for characterization of drugs and their receptors. There are three major families of opioid receptors: mu, delta, and kappa. Highly selective radioligands are available for all three classes of traditional receptors. Of the three, the mu receptor undergoes extensive alternative splicing, generating a number of traditional mu receptor subtypes as well as a nontraditional, truncated set of variants associated with exon 11. These exon 11-associated truncated variants are not readily labeled with current radioligands. Here we describe the synthesis of a radioiodinated ligand suitable for carrying out binding studies for this target.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Neuroscience Sf (1980) 1980 short course syllabus: receptor binding techniques. Society for Neuroscience, Washington, DC
Chavkin C, Goldstein A (1981) Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexus. Nature 291:591–594
Kosterlitz HW, Paterson SJ, Robson LE (1981) Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain. Br J Pharmacol 73:939–949
Clark JA, Liu L, Price M, Hersh B, Edelson M, Pasternak GW (1989) Kappa opiate receptor multiplicity: Evidence for two U50,488-sensitive kappa1 subtypes and a novel kappa3 subtype. J Pharmacol Exp Ther 251(2):461–468
Majumdar S, Burgman M, Haselton N, Grinnell S, Ocampo J, Pasternak AR, Pasternak GW (2011) Generation of novel radiolabeled opiates through site-selective iodination. Bioorg Med Chem Lett 21:4001–4004
Majumdar S, Grinnell S, Le Rouzic V, Burgman M, Polikar L, Ansonoff M, Pintar J, Pan YX, Pasternak GW (2011) Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects. Proc Natl Acad Sci USA 108:19776–19783
Majumdar S, Subrath J, Le Rouzic V, Polikar L, Burgman M, Nagakura K, Ocampo J, Haselton N, Pasternak AR, Grinnell S et al (2012) Synthesis and evaluation of aryl-naloxamide opiate analgesics targeting truncated exon 11-associated mu opioid receptor (MOR-1) splice variants. J Med Chem 55(14):6352–6362
Pasternak GW, Wilson HA, Snyder SH (1975) Differential effects of protein-modifying reagants on receptor binding of opiate agonists and antagonists. Mol Pharmacol 11:340–351
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Pasternak GW, Goodman R, Snyder SH (1975) An endogenous morphine like factor in mammalian brain. Life Sci 16:1765–1769
Pert CB, Pasternak GW, Snyder SH (1973) Opiate agonists and antagonists discriminated by receptor binding in brain. Science 182:1359–1361
Pasternak GW, Snowman AS, Snyder SH (1975) Selective enhancement of [3H]opiate agonist binding by divalent cations. Mol Pharmacol 11:478–484
Creese I, Pasternak GW, Pert CB, Snyder SH (1975) Discrimination by temperature of opiate agonist and antagonist receptor binding. Life Sci 16(12):1837–1842
Cheng Y-C, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22(23):3099–3108
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Marrone, G.F., Majumdar, S., Pasternak, G.W. (2015). Radioligand Binding Assay for an Exon 11-Associated Mu Opioid Receptor Target. In: Filizola, M. (eds) G Protein-Coupled Receptors in Drug Discovery. Methods in Molecular Biology, vol 1335. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2914-6_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2914-6_16
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2913-9
Online ISBN: 978-1-4939-2914-6
eBook Packages: Springer Protocols